Hodgkin's Diseasefind mydrugscancerRandomized Study of Intensive MOPP-ABVD With or Without Low-Dose Total-Nodal Radiation Therapy in the Treatment of Stages IIB, IIIA2, IIIB, and IV Hodgkin's Disease in Pediatric Patients: A Pediatric Oncology Group StudyIdentification of Common Germinal-Center B-Cell Precursors in Two Patients with Both Hodgkin's Disease and Non-Hodgkin's LymphomaGallium Scans in the Management of Patients With Hodgkin's Disease: A Study of 101 PatientsAlternating MOPP and ABVD Chemotherapy Plus Mantle-Field Radiation Therapy in Patients With Massive Mediastinal Hodgkin's DiseaseSecond Cancer among Long-term Survivors from Hodgkin's DiseaseIncreased Mortality after Successful Treatment for Hodgkin's DiseaseHeterozygous Germline ATM Mutations Do Not Contribute to Radiation-Associated Malignancies After Hodgkin's DiseaseSalvage Radiotherapy in Patients With Relapsed and Refractory Hodgkin's Lymphoma: A Retrospective Analysis From the German Hodgkin Lymphoma Study GroupRandomized Comparison of ABVD Chemotherapy with a Strategy that Includes Radiation Therapy in Patients with Limited-Stage Hodgkin's Lymphoma: National Cancer Institute of Canada Clinical Trials Group and the Eastern Cooperative Oncology Group
Randomized Study of Intensive MOPP-ABVD With or Without Low-Dose Total-Nodal Radiation Therapy in the Treatment of Stages IIB, IIIA2, IIIB, and IV Hodgkin's Disease in Pediatric Patients: A Pediatric Oncology Group Study
Identification of Common Germinal-Center B-Cell Precursors in Two Patients with Both Hodgkin's Disease and Non-Hodgkin's Lymphoma
Alternating MOPP and ABVD Chemotherapy Plus Mantle-Field Radiation Therapy in Patients With Massive Mediastinal Hodgkin's Disease
Heterozygous Germline ATM Mutations Do Not Contribute to Radiation-Associated Malignancies After Hodgkin's Disease
Salvage Radiotherapy in Patients With Relapsed and Refractory Hodgkin's Lymphoma: A Retrospective Analysis From the German Hodgkin Lymphoma Study Group
Randomized Comparison of ABVD Chemotherapy with a Strategy that Includes Radiation Therapy in Patients with Limited-Stage Hodgkin's Lymphoma: National Cancer Institute of Canada Clinical Trials Group and the Eastern Cooperative Oncology Group